IP Library › Granted Patent US 9,840,493
Granted Patent B2
US 9,840,493 · App. 15/028,005 · Granted Dec 12, 2017

Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use

Inventors: Wenjin Yang (Foster City, CA); Qun Yin (Palo Alto, CA)
Assignee: SUTRO BIOPHARMA, INC.
C07D401/12A61K47/48215A61K47/48246A61K47/48384A61K47/48561A61K47/48584A61K47/48646C07D257/08C07D409/12C07K5/06139C07K16/22C07K16/28C07K16/2833C07K16/2878C07K16/40C12N9/93C12P21/00C12P21/02C07K2317/24C07K2317/40C07K2317/50C07K2317/526C07K2317/567C07K2317/76C12Y601/01001
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,840,493
App. No.
15/028,005
Granted
Dec 12, 2017
Kind
B2
Abstract

Provided herein are modified amino acids comprising a tetrazine groups according to Formula I: polypeptides, antibodies, payloads and conjugates comprising these modified amino acid residues derived from the modified amino acids, and methods of producing the polypeptides, antibodies, payloads and conjugates comprising the modified amino acid residues. The polypeptides, antibodies, payloads and conjugates are useful in methods of treatment and prevention, methods of detection and methods of diagnosis.

Claims (25)

1. A compound according to formula I:

or a salt thereof, wherein:

Ar is

V is a single bond, lower alkylene, or —W 1 —W 2 —;

one of W 1 and W 2 is absent or lower alkylene, and the other is —NH—, —O—, or —S—;

X 1 is —NH—, —O—, or —S—;

one of Z 1 , Z 2 , and Z 3 is —N— and the others of Z 1 , Z 2 , and Z 3 are each independently —CH—; and

R is lower alkyl.

2. The compound of claim 1 , wherein V is a single bond, —NH—, or —CH 2 NH—.

3. The compound of claim 1 , wherein:

V is a single bond, —NH—, or —CH 2 NH—; and

Ar is

4. The compound of claim 1 , wherein:

V is a single bond, —NH—, or —CH 2 NH—; and

Ar is

5. The compound of claim 1 , wherein:

V is a single bond, —NH—, or —CH 2 NH—; and

Ar is

6. The compound of claim 1 according to formula Ia:

7. The compound of claim 1 according to formula IV, V, VI or VII:

or a salt thereof, wherein V is a single bond, —NH—, or —CH 2 NH—.

8. The compound of claim 1 according to formula VIII or IX:

or a salt thereof, wherein V is a single bond, —NH—, or —CH 2 NH—.

9. The compound of claim 1 according to any one of formulas 2, 3, and 6-10:

or a salt thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2017
From: YANG, WENJIN; YIN, QUN
To: SUTRO BIOPHARMA, INC.
Reel/Frame 043784/0022 →
Continuity (2)
Provisional Application 61890118 · Oct 11, 2013
Related Publication 20160251336A1 · Sep 1, 2016